Core Points - JingTai Holdings (02228.HK) experienced a significant stock price increase of 12.42%, closing at HKD 7.42 per share [1] - The company announced a pipeline collaboration agreement with DoveTree, with a total order value of approximately HKD 470 billion (USD 59.9 billion) [1] - An initial payment of approximately HKD 4 billion (USD 510 million) has been received as part of the agreement [1] Summary by Categories Collaboration Details - JingTai Holdings and DoveTree have reached a collaboration on several preclinical stage large and small molecule innovative drug assets [1] - The collaboration will focus on new drug development targeting a series of DoveTree-specified targets, with DoveTree holding exclusive global development and commercialization rights [1] Financial Aspects - In addition to the initial payment, JingTai Holdings is entitled to receive approximately HKD 3.85 billion (USD 490 million) in further payments [1] - The potential milestone payments and sales shares could amount to approximately HKD 462 billion (USD 58.9 billion) [1] Industry Impact - This collaboration sets a new record for order size in the field of AI and robotics in new drug development [1]
晶泰控股收涨12.42%，签订约470亿港元创纪录大单